Drug intelligence / Profile preview

LIV-R

Development stage: Unknown
Lead developer: Ankh Pharmaceuticals
Administration: Oral

Overview

LIV-R is a branded herbal and Ayurvedic dietary supplement developed and marketed by Ankh Pharmaceuticals. It is positioned as a consumer health product designed to support liver function and general digestive wellness. As a multi-ingredient botanical formulation, it is part of a broader line of wellness supplements and is not classified as a clinical pharmaceutical candidate with specific molecular targets or regulated trial phases. The product is sold for general wellness indications rather than as a prescription medication for specific clinical pathologies.

Brand names: LIV-R

Beyond the preview

Go deeper on LIV-R.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIV-R.

Explore the full profile